About CD4pos CD25pos regulatory cells

Autoimmunity Reviews

Volumn 1, Issue 4, 2002, Pages 190-197

  Asseman, C ^a   Von Herrath, M ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Auto immune disease; CD25; LCMV; Regulatory; Tolerance

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE MARKER; INTERLEUKIN 2 RECEPTOR; AUTOANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL ACTIVITY; CELL POPULATION; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THYMUS; VIRUS IMMUNITY; ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS;

EID: 0038612761     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00054-X     Document Type: Review

References (36)

1. Sakaguchi S., Fukuma K., Kuribayashi K., Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med. 161:1985;72-87.
2. Taylor P.A., Noelle R.J., Blazar B.R. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med. 193:2001;1311-1318.
3. Kingsley C.I., Karim M., Bushell A.R., Wood K.J. CD25+ CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol. 168:2002;1080-1086.
4. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 192:2000;295-302.
5. Thornton A.E., Shevach E.M. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 188:1998;287-296.
6. Takahashi T., Kuniyasu Y., Toda M., et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 10:1998;1969-1980.
7. Papiernik M., de Moraes M.L., Pontoux C., Vasseur F., Penit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol. 10:1998;371-378.
8. Stephens L.A., Mason D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J Immunol. 165:2000;3105-3110.
9. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 193:2001;1285-1294.
10. Levings M.K., Sangregorio R., Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 193:2001;1295-1302.
11. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 193:2001;1303-1310.
12. Stephens L.A., Mottet C., Mason D., Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 31:2001;1247-1254.
13. Itoh M., Takahashi T., Sakaguchi N., et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 162:1999;5317-5326.
14. Jordan M.S., Boesteanu A., Reed A.J., et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2:2001;301-306.
15. Takahashi T., Tagami T., Yamazaki S., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 192:2000;303-310.
16. Gavin M.A., Clarke S.R., Negrou E., Gallegos A., Rudensky A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol. 3:2002;33-41.
17. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 164:2000;183-190.
18. McHugh R.S., Whitters M.J., Piccirillo C.A., et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16:2002;311-323.
19. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 194:2001;629-644.
20. Lee W.T., Yin X.M., Vitetta E.S. Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. J Immunol. 144:1990;3288-3295.
21. Piccirillo C.A., Shevach E.M. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol. 167:2001;1137-1140.
22. Bystry R.S., Aluvihare V., Welch K.A., Kallikourdis M., Betz A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2:2001;1126-1132.
23. Cederbom L., Hall H., Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 30:2000;1538-1543.
24. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
25. Groux H., O'Garra A., Bigler M., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
26. Homann D., Holz A., Bot A., et al. Autoreactive CD4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the IL-4/STAT6 pathway. Immunity. 11:1999;463-472.
27. Ermann J., Szanya V., Ford G.S., Paragas V., Fathman C.G., Lejon K. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J Immunol. 167:2001;4271-4275.
28. Seddon B., Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 189:1999;877-882.
29. Salomon B., Lenschow D.J., Rhee L., et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440.
30. Kumanogoh A., Wang X., Lee I., et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol. 166:2001;353-360.
31. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 3:2002;135-142.
32. Nocentini G., Giunchi L., Ronchetti S., et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA. 94:1997;6216-6221.
33. Gurney A.L., Marsters S.A., Huang R.M. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol. 9:1999;215-218.
34. Romagnoli P., Hudrisier D., van Meerwijk J.P. Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells. J Immunol. 168:2002;1644-1648.
35. Whitmire J.K., Ahmed R. The economy of T-cell memory: CD4+ recession in times of CD8+ stability? Nat Med. 7:2001;892-893.
36. Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 163:1999;5211-5218.